XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Mar. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 105.6 $ 141.8
Trade and other accounts receivable (less allowances of $6.0 million and $5.1 million respectively) 337.7 284.5
Inventories (less allowances of $26.5 million and $25.4 million respectively):    
Finished goods 206.8 188.3
Raw materials 101.4 89.3
Total inventories 308.2 277.6
Prepaid expenses 17.2 18.0
Prepaid income taxes 9.5 5.8
Other current assets 0.4 0.4
Total current assets 778.6 728.1
Net property, plant and equipment 213.7 214.4
Operating lease right-of-use assets 42.3 35.4
Goodwill 362.0 364.3
Other intangible assets 53.0 57.5
Deferred tax assets 6.2 6.4
Pension asset 160.8 159.8
Other non-current assets 7.2 5.0
Total assets 1,623.8 1,570.9
Current liabilities:    
Accounts payable 161.8 148.7
Accrued liabilities 156.5 166.5
Finance leases 0.0 0.1
Current portion of operating lease liabilities 14.1 12.4
Current portion of plant closure provisions 6.2 5.2
Current portion of accrued income taxes 13.7 3.7
Total current liabilities 352.3 336.6
Plant closure provisions, net of current portion 50.1 51.3
Operating lease liabilities, net of current portion 28.3 23.1
Accrued income taxes, net of current portion 27.8 30.6
Unrecognized tax benefits 16.3 16.3
Deferred tax liabilities 61.3 60.8
Pension liabilities and post-employment benefits 17.4 17.8
Other non-current liabilities 1.4 1.4
Total liabilities 554.9 537.9
Equity:    
Common stock, $0.01 par value, authorized 40,000,000 shares, issued 29,554,500 shares 0.3 0.3
Additional paid-in capital 349.6 346.7
Treasury stock (4,739,680 and 4,780,806 shares at cost, respectively) (90.6) (90.6)
Retained earnings 859.4 822.9
Accumulated other comprehensive loss (50.5) (46.9)
Total Innospec stockholders' equity 1,068.2 1,032.4
Non-controlling interest 0.7 0.6
Total equity 1,068.9 1,033.0
Total liabilities and equity $ 1,623.8 $ 1,570.9